Overview

Incorporating Patient Treatment Choice to Improve Treatment Retention in Depressed Hispanics

Status:
Completed
Trial end date:
2014-01-10
Target enrollment:
Participant gender:
Summary
This study will determine whether combination treatment driven by patient choice is better than standardized medication treatment at retaining and improving Hispanic patients with major depressive disorder.
Phase:
Phase 2
Details
Lead Sponsor:
New York State Psychiatric Institute
Collaborator:
National Institute of Mental Health (NIMH)
Treatments:
Antidepressive Agents
Bupropion